Explore the transformative dynamics shaping healthcare coverage and access in 2025, with a special focus on the most pressing trends and issues that are set to redefine the industry.

• Gauge the impact of the November 2024 elections on the direction of health policy at the federal level, especially as it relates to the Inflation Reduction Act and Affordable Care Act
• Gain insights into the evolving regulatory environment, including updates on the Part D benefit redesign and rollout of the Medicare Prescription Payment Plan
• Assess the continued prevalence of payer and employer models restricting the use of manufacturer-sponsored financial assistance
• Discuss potential policy solutions and strategies to address the barriers to healthcare access

In fall 2024, the PAN Foundation conducted national polling that illuminated a sobering statistic: 87% of Medicare beneficiaries had not seen, read, or heard anything about the Medicare Part D reforms to take effect January 1, 2025. The PAN Foundation has since led a national education effort to shift that statistic—and subsequently polled people with Medicare again in 2025 to measure the impact of educational outreach.

In this session: 

• Gain access to new research and insights on the current state of awareness among Medicare beneficiaries of the Part D cap and Medicare Prescription Payment Plan—and the role of education in shifting that awareness 

• Learn more about national educational efforts intended to increase awareness, knowledge and ultimately, patients’ ability to make empowered decisions around their healthcare 

• Discuss practical strategies to ensure patients know about these reforms, increase health literacy and provide access to high quality and culturally competent health information 

Diagnosed with Lupus in 2004, Shanelle has dedicated her life to raising awareness, amplifying patient voices and pushing for greater diversity in healthcare. With spoken word and musical performances on global stages like Lincoln Center to the Vatican and advocacy work spanning from Capitol Hill to clinical trial awareness, Shanelle brings a unique perspective to the patient experience. As a member of the Lupus Voices Council and a celebrated artist, Shanelle will share her powerful journey of resilience, creativity and the role of art in patient engagement.

In this exclusive roundtable, industry leaders will dive deep into how patient access needs are being assessed and the critical role affordability plays in shaping healthcare decisions. With a focus on real-world strategies and emerging trends, explore how data-driven insights are informing policy, operational changes and innovative approaches to patient support.

A Visionary's Journey – An Intimate Conversation with a Rare Disease Leader

Join us for an intimate conversation with Chris Peetz to discover the challenges and rewards of leading a company focused on bringing innovative treatments to the rare market. From his entrepreneurial journey to his experiences as an executive in the pharmaceutical industry, uncover his inspiring pursuit of innovation as well as his valuable perspective on the future of rare disease.

This session will explore the complex interplay of the various stakeholders involved in bringing rare disease therapies to market.

• Increase understanding of the unique challenges and opportunities associated with rare disease commercialization

• Foster collaboration and communication among key stakeholders in the rare disease community

• Explore strategies for improving access to innovative treatments for patients with rare diseases

The dynamic between industry and advocacy has evolved significantly, only increasing the need for innovative collaboration approaches to optimize patient outcomes.

• Benchmark best practices for fostering high-impact collaborations and explore successful models of partnership

• Gain insights on how to quantify the value of advocacy contributions and benchmark innovative initiatives to drive future collaborations

• Equip your organization with tools to build more effective and impactful partnerships